Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Shares, par value (euro)0.12 per share
-
Shares outstanding
-
22,421,536
-
Total 13F shares
-
33,716,537
-
Share change
-
-2,016,593
-
Total reported value
-
$230,128,246
-
Put/Call ratio
-
17%
-
Price per share
-
$6.83
-
Number of holders
-
84
-
Value change
-
-$14,892,714
-
Number of buys
-
44
-
Number of sells
-
39
Institutional Holders of CureVac N.V. - Common Shares, par value (euro)0.12 per share (CVAC) as of Q3 2023
As of 30 Sep 2023 CureVac N.V. - Common Shares, par value (euro)0.12 per share (CVAC) had 84 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 33,716,537 shares of stock of the company.
Largest 10 holders included RA CAPITAL MANAGEMENT, L.P., PRICE T ROWE ASSOCIATES INC /MD/, Avidity Partners Management LP, CITADEL ADVISORS LLC, BlackRock Inc., MILLENNIUM MANAGEMENT LLC, Camber Capital Management LP, Bill & Melinda Gates Foundation, Alyeska Investment Group, L.P., and Eversept Partners, LP.
This table shows 84 institutional shareholders of the security as of 30 Sep 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.